Phio Pharmaceuticals Corp. (PHIO )

Currency in USD Disclaimer
$2.04 -$0.47 (-18.73%)
Open 04/24/2025
$2
$2.5
$0.97
$9.79

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol PHIO
  • Company Phio Pharmaceuticals Corp.
  • Price $2.04
  • Changes Percentage -18.73
  • Change -0.47
  • Day Low $2
  • Day High $2.5
  • Year High $9.79
  • Year Low $0.97
  • Market Cap $9,747,434
  • Price Avg 50 EMA (D) $1.57
  • Price Avg 200 EMA (D) $2.61
  • Exchange NASDAQ
  • Volume 960,900
  • Average Volume 3,218,495
  • Open $2.47
  • Previous Close $2.51
  • EPS -9.08
  • PE -0.22
  • Earnings Announcement 2025-05-07 20:00:00
  • Shares Outstanding $4,778,154

Company brief: PHIO PHARMACEUTICALS CORP. (PHIO )

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

PHIO Corporation News

Best Value Stocks to Buy for April 23rd

Best Value Stocks to Buy for April 23rd

April 23, 2025 at 11:46 am ET

zacks.com -- PHIO and TGS made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 23, 2025....

Income Statement